
Modulateurs d'enzymes
Sous-catégories appartenant à la catégorie "Modulateurs d'enzymes"
644 produits trouvés pour "Modulateurs d'enzymes".
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
(S)-Mephenytoin - Bio-X ™
CAS :(S)-Mephenytoin is a substrate of cytochrome P450 enzyme CYP2C19 (a hydroxylase). It is an effective anticonvulsant that improves control of seizures in patients. According to studies, the drug exhibits a genetic polymorphism in CYP2C19 that results in reduced metabolism in some individuals.Formule :C12H14N2O2Degré de pureté :Min. 97 Area-%Couleur et forme :White PowderMasse moléculaire :218.25 g/molPLX 4032
CAS :BRAF kinase inhibitor; antineoplasticFormule :C23H18ClF2N3O3SDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :489.92 g/molKifunensine - Bio-X ™
CAS :Kifunensine is a small molecule inhibitor that was designed and synthesized to inhibit plant and animal α-mannosidase I. It is a potent and specific inhibitor with IC50 in nanomolar range. It inhibits the enzyme isoforms in Golgi apparatus (GMI) and endoplasmatic reticulum (ERMI). The compound prevents mannose trimming on glycoproteins and shifts the glycoform content from complex to oligomannose type. Used for the production of recombinant therapeutic glycoproteins with mannose rich N-linked glycans.Formule :C8H12N2O6Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :232.19 g/molBRD 6989
CAS :A small molecule inhibitor with high selectivity for CDK8 over CDK19. Increases IL-10 production in stimulated human and murine macrophages and dendritic cells. Modulatory action on inflammatory responses has therapeutic potential.Formule :C16H16N4Degré de pureté :Min. 95%Couleur et forme :SolidMasse moléculaire :264.33 g/molMLi-2
CAS :A brain-penetrant inhibitor of leucin-rich repeat kinase 2 (LRRK2) with IC50 = 0.76 nM and anti-parkinsonian activity. Gain-of-function mutations in LRRK2 gene lead to increased familial and idiopathic risk of developing the disease. The inhibitors of the kinase activity have therapeutic potential against Parkinson’s disease.
Formule :C21H25N5O2Degré de pureté :Min. 98 Area-%Couleur et forme :PowderMasse moléculaire :379.46 g/molQ-VD-OPH
CAS :Inhibitor of caspases; broad spectrumFormule :C26H25F2N3O6Degré de pureté :Min. 98.00 Area-%Couleur et forme :PowderMasse moléculaire :513.49 g/molN-alpha-Benzoyl-L-argininamide
CAS :N-alpha-Benzoyl-L-argininamide is a synthetic compound that is used as an enzyme inhibitor. It binds to the active site of proteases, thereby inhibiting their activity. This drug has been shown to inhibit the activities of phosphodiesterase and phosphatase enzymes in vitro. N-alpha-Benzoyl-L-argininamide also inhibits the proteolytic degradation of hippuric acid and casein in vitro. The binding affinity for this drug is due to its structural similarity with substrates such as glutamate and rhizosphere exudates.
Formule :C13H19N5O2Degré de pureté :Min 98%Couleur et forme :White PowderMasse moléculaire :277.32 g/molVolitinib
CAS :Inhibitor of c-Met kinaseFormule :C17H15N9Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :345.36 g/molSorafenib - Bio-X ™
CAS :Sorafenib is a drug that belongs to the class of multikinase inhibitors. It inhibits a number of kinases, including the Mcl-1 protein, which is involved in apoptosis along with blocking picolinic acid (PA), an endogenous metabolite involved in apoptosis signal transduction. Sorafenib also binds to epidermal growth factor receptor (EGFR) on the surface of cancer cells, inhibiting the production of proteins that are required for angiogenesis, thus blocking the formation of new blood vessels. Sorafenib may also inhibit P-glycoprotein (Pgp) activity. Overall, these cytotoxic effects give Sorafenib anti-tumor properties, inhibiting angiogenesis and cellular transformation, which are the two main processes of tumor growth and metastasis. Sorafenib has been shown to be effective against a range of solid tumors such as breast, prostate and lung cancers and is also used for the treatment of metastatic colorectal cancer and renal cell carcinoma. A combination therapy group found that sorafenib was more effective when used with interferon alfa-2b for the treatment of advanced renal cell carcinoma. Sorafenib also has the potential for drug interactions with other drugs that are metabolized by cytochrome P450 enzymes. Sorafenib is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready to use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.Formule :C21H16ClF3N4O3Degré de pureté :Min. 98%Couleur et forme :PowderMasse moléculaire :464.82 g/molSeratrodast - Bio-X ™
CAS :Seratrodast is a thromboxane receptor antagonist that is used to treat asthma. However, this drug does not affect thrombus formation as other thromboxane synthase inhibitors do such as ozagrel.Formule :C22H26O4Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :354.44 g/molLumiracoxib - Bio-X ™
CAS :Produit contrôléLumiracoxib is a COX-2 selective non-steroidal anti-inflammatory drug that is used for the treatment of osteoarthritis. This drug inhibits prostaglandin synthesis via inhibition of COX-2.Formule :C15H13ClFNO2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :293.72 g/molDovitinib base
CAS :Receptor tyrosine kinase inhibitor; anti-angiogenesis; anti-oncogenesisFormule :C21H21FN6ODegré de pureté :Min. 98 Area-%Couleur et forme :PowderMasse moléculaire :392.43 g/molCHIR 99021
CAS :Potent and selective inhibitor of the glycogen synthase kinase GSK-3. Promotes cell renewal in embryonic stem cells by modulating Notch, MAPK and TGF-β signalling pathways, which are involved in pluripotency. It also affects the Wnt/β-catenin pathway and alters expression of genes coding for proteins, epigenetic regulatory elements and non-coding RNAs. The combination of CHIR 99021 and basic fibroblast growth factor (bFGF) allows long-term self-renewal in adult mouse retinal progenitor cells.Formule :C22H18Cl2N8Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :465.34 g/molLOXO-305
CAS :LOXO-305 is a small molecule inhibitor, which is a synthesized chemical compound designed to selectively target specific enzymes or pathways. Its source is rooted in medicinal chemistry and pharmacological research aimed at elucidating pathways involved in oncogenesis.
Formule :C22H21F4N5O3Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :479.43 g/molR-(-)-Arundic acid
CAS :R-(-)-Arundic acid is a chiral compound, which is a derivative of arundic acid specifically designed for enantiomeric purity. It is sourced through synthetic organic chemistry processes, allowing for precise control over its stereochemistry. The mode of action of R-(-)-Arundic acid involves the inhibition of astrocyte activation by modulating the synthesis of certain cytokines and inflammatory mediators. This mechanism provides a neuroprotective effect, making it a valuable tool in the study of neurodegenerative diseases and brain injuries.
Formule :C11H22O2Degré de pureté :Min. 98 Area-%Couleur et forme :Clear Viscous LiquidMasse moléculaire :186.29 g/molAnastrozole - Bio-X ™
CAS :Produit contrôléAnastrozole is a non-steroidal drug that belongs to the class of aromatase inhibitors. It inhibits the production of estrogen by blocking the conversion of androgens to estrogens in peripheral tissues. The drug has been shown to be effective in treating breast cancer in postmenopausal women. In vitro assays have shown that Anastrozole can inhibit tumor growth as well as induce apoptosis in human serum cells, which suggests that it may be effective against a variety of cancers.
Formule :C17H19N5Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :293.37 g/molBrivanib alaninate
CAS :VEGFR2 a tyrosine kinase receptor inhibitor; antineoplasticFormule :C22H24FN5O4Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :441.18123Ulixertinib
CAS :Inhibitor of ERK1 and ERK2 kinasesFormule :C21H22Cl2N4O2Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :433.33 g/molAG 221
CAS :Inhibitor of isocitrate dehydrogenase 2Formule :C19H17F6N7ODegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :473.38 g/mol
